Protocol
Biobrick Protocol
-
Western Blotting protocol
1、Prepare of Proteins
1.1 Culture E.coli BL21(DE3) with LB(l) medium overnight at 37℃, 200rpm
1.2 Add 1ml overnight culture into 5ml new LB(l) medium for 1 hour at 37℃, 200rpm
1.3 Induce culture by IPTG (with final concentration of 0.5mM) more than 4 hours, while the OD600 is 0.6
1.4 (Lysis) Add 1.5ml lysozyme (1mg/ml) into 2ml centrifuged and the supernatant discadred strain, 30℃ for 30 minutes
1.5 (Degeneration) Add SDS loading buffer and put the centrifugal tube into boiled water for 10 minutes
2、Prepare SDS-PAGE gel, Running buffer, Trans buffer and TBST Washing buffer
SDS-PAGE:
12% Separation Gel(the lower gel):
30%Acr-Bis 3.2ml
1.5M Tris-HCl(pH=8.8) 2ml
10%SDS 80μl
10%AP 80μl
TEMED 3μl
H2O 2.64ml
Total 8ml
5% Spacer Gel(the upper gel):
30%Acr-Bis 500μl
1.5M Tris-HCl(pH=6.8) 500μl
10%SDS 40μl
10%AP 30μl
TEMED 3μl
H2O 2ml
Total 3ml
1×Running buffer:
Tris 3.03g
Glycine 14.4g
10%SDS 10ml
Add ultra pure water to 1L
Store at 4℃
1×Trans buffer:
Tris 3.03g
Glycine 14.4g
10%SDS 10ml
Methanol 200ml
Add ultra pure water to 1L
Store at 4℃
1×TBS buffer:
Tris 2.4g
NaCl 8.7g
Adjust pH=7.6 with HCl
Add ultra pure water to 1L
TBST Washing buffer:
TBS 500ml
Tween-20 250μl
Blocking buffer:
Add 2.5g no-fat dry milk into 50ml TBST Washing buffer
Prepare Blocking buffer only when using it
3、Protein transfer and Immunodetection
3.1 Add 15μl sample and 5μl Protein marker
3.2 Add Running buffer for electrophoresis with a constant voltage at 100V for about 25 minutes, then change voltage into 200V for 40 minutes (adjust the former time by the marker)
3.3 Open the package and cut the upper spacer gel
3.4 Prepare the same size PVDF membrane and put into Trans buffer for 5 minutes before trans-membrane
3.5 Open gel cassettes and put the gel on the PVDF membrane sandwiched between two pieces of blotting paper(always filter paper)
Mind the order of gel and PVDF membrane between the electrodes, black end with gel for negative electrode and white end with PVDF membrane for positive electrode.
3.6 Add Trans buffer for electrophoresis with a constant current at 350mA for 65 minutes(Crowd with ice at a 4℃ temperature )
3.7 After trans-membrane, wash PVDF membrane with 10ml TBST for 10 minutes with gentle shaking
3.8 Add 10ml Blocking buffer with gentle shaking for 1 hour at room temperature or 4℃ overnight
3.9 Wash PVDF membrane with 10ml TBST for 10 minutes with gentle shaking
3.10 Add 10ml diluted(1:5000) primary antibody for 2 hours at room temperature or 4℃ overnight with gentle shaking (primary antibody can be used repeatedly for 10 times)
3.11 repeat step 3.9
3.12 Add 10ml diluted secondary conjugated antibody for 2 hours at room temperature or 4℃ overnight with gentle shaking (seconfary antibody needn’t be repeatedly used)
3.13 repeat step 3.9
3.14 With the ratio of 1:1 to mix Luminous substrate A and B, typically 200-400μl mixture added on PVDF membrane
3.15 Take photos by specific machine and store it
-
CRC induction
Subject: C57BL/6 mice strain (6~8 week old)
Material: Azoxymethane (AOM) solution (1mg/ml)
Dextran Sulfate Sodium Salt (DSS) solution (2.0% & 2.5%)
Experiment aim:
After analyzing the qualities of our device that requires testifying meanwhile thoroughly considering the 3Rs principle, we have reduced the need of animal experiments to the least, but for certain qualities the testifying procedure is difficult to replace, refine and reduce experimental animals use. As a result the colorectal cancer mouse model was induced in the minimum amount just to be adequate for product testifying procedure.
Experiment design:
Azoxymethane (AOM) is a chemical agent that can initiate cancer by alkylation of DNA, there by facilitating base mispairings, while Dextran Sulfate Sodium Salt (DSS) is a substance that causes inflammations that will eventually lead to enteritidis.
After being injected into the subject, AOM introduces a carcinogenic environment in vivo, along with DSS consumed, enteritidis is likely to occur and soon develop into colorectal cancer.
Experimental procedure:
After the mice strain stabilizes and being weighed, intraperitoneal injection of AOM solution is given in the amount of 10mg/kg and let rest for a week.
With the AOM injection completed, the DSS induction process begins. One induction cycle lasts for 3 weeks while the complete induction process includes 3 cycles of which. In the first week of the three-week cycle the DSS solution (2.0% & 2.5%) was given as drinking water to our subject. DSS solution was mixed right before it was given to subject to ensure the best results. After one week of consuming DSS, the drinking water for the next two weeks was switched to normal clear water. Repeat the cycle two more times while carefully monitor the weight change of the subject.
Citation:
[1]Ameet I. Thaker, Anisa Shaker, M. Suprada Rao, Matthew A. Ciorba,Modeling Colitis-Associated Cancer with Azoxymethane (AOM) and Dextran Sulfate Sodium (DSS) ,Journal of Visualized Experiments,9/11/2012
[2]Clemens Neufert, Christoph Becker & Markus F Neurath,An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression,NatureProtocol, 9/08/2007 -
Structure observation of CRC models—paraffin sectioning and HE staining
Subject: Colorectal tissue from CRC induced mouse model and normal ones
Material: PBS, different concentration of ethanol (50%, 75%, 85%, 95%, 100%), xylene, paraffin wax, haematoxylin and eosin (HE stain)
Experiment aim:
Before using our CRC mouse model for any further experiment, it is essential to first testify the existence of the disease. The exquisite imaging of the cancerous area is also critical in modeling as well as device improvement.
Experiment design:
To maintain the original structure of the tissue, the paraffin sectioning was carry out. After receiving a clear and complete biopsy of the sample, haematoxylin and eosin (HE) stain was performed to get the best vision of the histological structure.
Experiment procedure:
First, a section of colon or rectum was removed from the subjects and longitudinally cut open to form a rectangular piece of tissue. The tissue was then placed on a small cardboard and soaked in paraformaldehyde (PFA) solution overnight. Then the tissue was washed with phosphate buffered saline solution (PBS) three times (10minutes each time). With the tissue cleared from PFA, a series of soaking process was done on decoloring shaker. The soaking process was shown in table below for better understanding.(table here)
After the soaking process the samples were then embedded in paraffin wax and sliced into biopsy of 10μm thick. They were gently flushed with PBS before the haematoxylin was applied and let sit in the dark for 4 minutes. Haematoxylin was then removed and the samples were rinsed and flushed in ddH2O for 5 minutes. Add 4 drops of HCl-Ethanol (1ml HCl+400ml ethanol) and rapidly dip the sample in ddH2O where a 2-minute flush as well as a 2-minute soaking were performed. Eosin was applied and last on the biopsy for 15 seconds before it was flushed out gently using ddH2O. Similar to the paraffin sectioning, a series of soaking process on decoloring shaker was involved and mentioned in table below. The biopsy was let dry in room temperature and sealed with neutral balsam to complete the HE stained slide.(table here) -
Examination of T antigen expression level
The examination involved two examining method: the cellular level examination and the biopsy examination.
Subject: Colorectal tissue from CRC induced mouse model and normal ones
Material: Trypsin, PNA-FITC, PBS, ddH2O
Experiment aim:
Through document material we knew that the T antigen expression level of cancerous area is much higher than normal tissue, and this characteristic plays an important role in our project design. So before we started to testify our product’s quality, it is essential to solidify the foundation of our product design. Experiment design:
In this experiment we use the fluorescent level of PNA-FITC to indicate the expression of T antigen. PNA-FITC is a plant lectin protein that binds with the sugar that contains carbohydrate sequence Gal-β(1-3)-GalNAc, a sequence also carries by our testifying target, T antigen. Also, the frozen section of the tissue makes the binding with cellular dye better to observe. After adequate binding time being given, we can compare the fluorescent level of CRC mouse model with normal ones to reach to our conclusion.
Experimental procedure:
C.1 cellular level examination
First, the colorectal tissue was removed from the subjects and digested by trypsin under 37°C for 15~20 minutes. The volume of the trypsin used is four times of the sample with the concentration of 0.25%. The liquid should then be centrifuged for 10 minutes in 1000XG and remove the supernatant to eliminate further damage by trypsin remained. Phosphate buffered saline (PBS) was added to the remains before the samples were resuspended. The mixture were then filtered through 50μm filter membrane and transport to new lightproof sample tubes. A drop of the sample was drawn and observed under microscope to ensure the density of which is around 106cell/ml. If the cell number is lower than target, the samples should be centrifuged again and withdraw certain amount of the supernatant. While in higher cell count situation, extra PBS should be added to dilute the sample to the ultimate density.
Then PNA-FITC(1μg/ml) was added to the samples and was incubated under 37°C for 30 minutes. Centrifuge the samples for 10 minutes in 1000XG and replace the supernatant with clear PBS to eliminate the possible interrupting signals caused by unbunded PNA-FITC. Our samples were then measured using flow cytometry. When using the cytometry we circled out the living cells on the graph and compare the fluorescent level chart between CRC models and normal mouse.
C.2 Biopsy examination
The tissue was fixed by frozen section before we apply PNA-FITC on to the biopsy. So first, a section of colon or rectum was removed from the subjects and longitudinally cut open to form a rectangular piece of tissue. The tissue was then placed on a small cardboard and soaked in paraformaldehyde (PFA) solution overnight. The soaking solution was then switched to 30% sucrose solution and last for another night. Put the tissue in freezing solution and freeze under -20°C overnight to prepare the following biopsy. The properly frozen tissue were sliced into biopsy of 10μm thick.
In the following procedure we refer PNA-FITC to as the primary antibody and carry out the standard procedure of immunohistochemical test. The biopsy was first flushed with 0.1% tween-20 phosphate buffered saline solution (PBST) three times (10minutes each time), and then the blocking liquid (5% FBS+0.1% Triton X-100) was added with the incubation last for an hour. After removing the blocking liquid the samples require another three-time flushing by PBST. At last PNA-FITC (50μg/ml) was added and the samples were incubated in 4°C overnight. Before being observed under fluorescent microscope, a three-time PBST flushing was done again. The final samples were sealed with mounting medium that contains 4′,6-diamidino-2-phenylindole (DAPI) for better vision on the structure as well.
-
Bacterial adhesion property examination
Subject: Colorectal tissue from CRC induced mouse model and normal ones Material: Two types of engineered bacteria: A. bacteria with surface peptide
expression and GFP
B. bacteria with only GFP
PBS
Experiment aim:
After solidifying the distinguishing T antigen expression level in experiment B as well as the adhesion property in cellular level, it is time to apply our product directly on tissue to determine the adhesion property in real situation.
Experimental design:
Since the overall examination of fluorescent level of the tissue is difficult to perform, we’ve decided to apply our device straight on the tissue before performing a frozen section. Frozen section comparing to paraffin section enables the tissue to maintain the binding with bacteria better so it was performed soon after the bacterial adhesion procedure.
Experimental procedure:
First, a section of colon or rectum was removed from the subjects and longitudinally cut open to form a rectangular piece of tissue. The tissue were then placed on a small cardboard and soaked in paraformaldehyde (PFA) solution overnight. The soaking solution was then switched to sucrose solution (40%) and last for another night. Meanwhile our engineered bacteria were incubated and induced until the final OD600=1 with obvious GFP observed under fluorescent microscope.
Then, the tissue were separately put in the two kind of bacteria media and were incubated under 37°C for 30 minutes. After the incubation the tissue were soaked in PBS and gently washed for three times using PBS. Put the tissue in freezing solution and freeze under -20°C overnight to prepare for the following biopsy. The properly frozen tissue were slice into pieces of 10μm thick to form a biopsy. The biopsy was then observed under fluorescent microscope to compare the aggregation of the glowing bacteria.
-
Ultrasound signal examination
Subject: colorectal section from CRC induced mouse model and normal ones
Materials: Two types of engineered bacteria:
A. Vesicles induced bacteria
B. Vesicles induced bacteria with surface peptide expression
C. Bacteria with no vesicles (with only EFP)
Experiment aim:
The ultimate goal of our device is to enable vitro detection of CRC via ultrasound, so the demonstration of the ultrasound signal results from our device is undoubtedly essential. Since the signal from bacterium gel was previously testified, we’ve then moved on to observe signal from our mouse models in order to analyze the quality and feasibility of our product.
This experiment involves two different procedures in order to reach different conclusions. For the first procedure which uses vesicles induced bacteria and bacteria with no vesicles, we would like to testify whether the vesicle signal results from our device is visible and breakable under ultrasound; as for the second procedure involving vesicles induced bacteria and vesicles induced bacteria with surface peptide expression, the specificity of bindings between surface peptide and T antigen as well as the actual signal difference were being determined.
Experimental design:
Before introducing engineered bacteria into our mouse models digesting system, we would like to start with applying our device on removed colorectal section in vitro. Also in order to push our device step by step toward completeness as well as to lay solid foundation for further demonstration, our experiments were first conducted on an ideal model. To create the ideal model, we’ve removed the possible interruption inside the intestines meanwhile creating a system where ultrasound could be easily observed.
Experimental procedure:
A section of colon or rectum (2cm~3cm) was removed from the subjects with the faeces inside removed. The whole section was then washed with PBS while the testinal mucosa remained. The flowing procedure differs between bacteria types.
E.1 Vesicles induced bacteria comparing with bacteria with no vesicles.
In this part of experiment our subjects were colorectal sections from normal mice. Before introducing bacteria into the intestines, the bacterial suspension was mixed with agarose to form a 0.2% agarose solution. The solution was then pumped into the colorectal section carefully using syringe. After the injection the intestine was clamped at both sides to let set the solution. We chose 6-well culture plate as the container for our samples and sealed our sample in 0.4% agarose for better ultrasound observation. The samples were then observed under ultrasound with the frequency of 21mHz.Fig1.Schematic of ultrasound sampling for E.1 experiment
As for this part of experiment our subjects included colorectal sections from both normal mice and CRC induced mouse models. After realizing signal observation inside the intestines, we moved onto testifying the specificity of peptide binding. Similar to the procedure mentioned above, the bacterial suspension was mixed with agarose to form a 0.2% agarose solution and pumped into our samples to form a gel inside the intestines. The difference lied in the way of how our samples were placed in the container. First we poured 0.5% agarose gel into the well with a round model standing in the middle, forming a sunken space. The samples were then placed in this space to build a “standing” sample. Slowly pour 0.2%agarose into the gap to stabilize the sample. After solidification the projecting part above the gel were removed to form a smooth gel service for ultrasound examination. The samples were then observed under ultrasound with the frequency of 21mHz. -
Western Blotting protocol
1、Prepare of Proteins
1.1 Culture E.coli BL21(DE3) with LB(l) medium overnight at 37℃, 200rpm
1.2 Add 1ml overnight culture into 5ml new LB(l) medium for 1 hour at 37℃, 200rpm
1.3 Induce culture by IPTG (with final concentration of 0.5mM) more than 4 hours, while the OD600 is 0.6
1.4 (Lysis) Add 1.5ml lysozyme (1mg/ml) into 2ml centrifuged and the supernatant discadred strain, 30℃ for 30 minutes
1.5 (Degeneration) Add SDS loading buffer and put the centrifugal tube into boiled water for 10 minutes
2、Prepare SDS-PAGE gel, Running buffer, Trans buffer and TBST Washing buffer
SDS-PAGE:
12% Separation Gel(the lower gel):
30%Acr-Bis 3.2ml
1.5M Tris-HCl(pH=8.8) 2ml
10%SDS 80μl
10%AP 80μl
TEMED 3μl
H2O 2.64ml
Total 8ml
5% Spacer Gel(the upper gel):
30%Acr-Bis 500μl
1.5M Tris-HCl(pH=6.8) 500μl
10%SDS 40μl
10%AP 30μl
TEMED 3μl
H2O 2ml
Total 3ml
1×Running buffer:
Tris 3.03g
Glycine 14.4g
10%SDS 10ml
Add ultra pure water to 1L
Store at 4℃
1×Trans buffer:
Tris 3.03g
Glycine 14.4g
10%SDS 10ml
Methanol 200ml
Add ultra pure water to 1L
Store at 4℃
1×TBS buffer:
Tris 2.4g
NaCl 8.7g
Adjust pH=7.6 with HCl
Add ultra pure water to 1L
TBST Washing buffer:
TBS 500ml
Tween-20 250μl
Blocking buffer:
Add 2.5g no-fat dry milk into 50ml TBST Washing buffer
Prepare Blocking buffer only when using it
3、Protein transfer and Immunodetection
3.1 Add 15μl sample and 5μl Protein marker
3.2 Add Running buffer for electrophoresis with a constant voltage at 100V for about 25 minutes, then change voltage into 200V for 40 minutes (adjust the former time by the marker)
3.3 Open the package and cut the upper spacer gel
3.4 Prepare the same size PVDF membrane and put into Trans buffer for 5 minutes before trans-membrane
3.5 Open gel cassettes and put the gel on the PVDF membrane sandwiched between two pieces of blotting paper(always filter paper)
Mind the order of gel and PVDF membrane between the electrodes, black end with gel for negative electrode and white end with PVDF membrane for positive electrode.
3.6 Add Trans buffer for electrophoresis with a constant current at 350mA for 65 minutes(Crowd with ice at a 4℃ temperature )
3.7 After trans-membrane, wash PVDF membrane with 10ml TBST for 10 minutes with gentle shaking
3.8 Add 10ml Blocking buffer with gentle shaking for 1 hour at room temperature or 4℃ overnight
3.9 Wash PVDF membrane with 10ml TBST for 10 minutes with gentle shaking
3.10 Add 10ml diluted(1:5000) primary antibody for 2 hours at room temperature or 4℃ overnight with gentle shaking (primary antibody can be used repeatedly for 10 times)
3.11 repeat step 3.9
3.12 Add 10ml diluted secondary conjugated antibody for 2 hours at room temperature or 4℃ overnight with gentle shaking (seconfary antibody needn’t be repeatedly used)
3.13 repeat step 3.9
3.14 With the ratio of 1:1 to mix Luminous substrate A and B, typically 200-400μl mixture added on PVDF membrane
3.15 Take photos by specific machine and store it
-
Your title1
xxx xx xxxx xxx xxx xxx xx xxxx xxx xxxxx xxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxx
-
Your title2
xxx xx xxxx xxx xxx xxx xx xxxx xxx xxxxx xxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxx
-
Your title3
xxx xx xxxx xxx xxx xxx xx xxxx xxx xxxxx xxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxxx xx xxxx xxx xxxxxxx
- Frequency: 21MHz
- Power for imaging: min(2%)
- Power for collapse: max(100%) (sustaining for 5 minutes)
- Max frame: 50
- Gain: 16dB
- Focus: adjust to the depth of the layer where engineered E.coli lies in.
- Field of view: adjust to achieve the maximum repression of noise and also zoom in on the interest region as much as possible.
Mouse experiments
Section3
xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx. The text-link template is here.
2018 Interlab Plate Reader ProtocolProtocols/Transformation
Instructions: you have the change not only the main text, but also have to modify the text in the navgation bar on the left side. Now put your content here and do the same for the following sections. xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx Note template is here ---
OD
OD
Optical density
.
Section
xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxxxxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxxxxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx
Section3
xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx. The text-link template is here.
2018 Interlab Plate Reader Protocol
Protocols/Transformation
section4
xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx The figure template is here.
Fig 1. The particle standard curve obtained form the 2nd calibration experiment.
section4
xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx The figure template is here.
Fig 1. The particle standard curve obtained form the 2nd calibration experiment.
xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx.
The table template is here.
Table 1. Colony forming units per 0.1 OD600
samples
dilution factor
CFU/mL
8×104
8×105
8×106
1.1 TNTC 48 11 3.84E+07
1.2 248 41 10 3.28E+07
1.3 172 54 5 4.32E+07
2.1 TNTC 143 20 1.14E+08
2.2 TNTC 153 25 1.22E+08
2.3 TNTC 151 18 1.21E+08
3.1 TNTC 119 16 9.52E+07
3.2 TNTC 125 19 1.00E+08
3.3 TNTC 89 18 7.12E+07
4.1 TNTC 209 16 1.67E+08
4.2 TNTC 130 17 1.04E+08
4.3 TNTC 164 10 1.31E+08
US imaging
We use the Fujifilm VisualSonics / VEVO LAZR-X imaging system and MX250 transducer. The application is set to VA Phantom. Parameters are listed below:
Preparation before imaging: PBS solution is needed to cover the imaging samples allowing the transducer to dip into the solution. Pay attention to not producing any unwanted bubbles.
Instructions: you have the change not only the main text, but also have to modify the text in the navgation bar on the left side. Now put your content here and do the same for the following sections. xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx Note template is here --- OD OD Optical density .
Section
xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxxxxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxxxxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx
Section3
xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx. The text-link template is here.
2018 Interlab Plate Reader ProtocolProtocols/Transformation
section4
xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx The figure template is here.
Fig 1. The particle standard curve obtained form the 2nd calibration experiment.
xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx The figure template is here.
Fig 1. The particle standard curve obtained form the 2nd calibration experiment.
xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx xxx.
The table template is here.
Table 1. Colony forming units per 0.1 OD600
samples | dilution factor | CFU/mL | ||
---|---|---|---|---|
8×104 | 8×105 | 8×106 | ||
1.1 | TNTC | 48 | 11 | 3.84E+07 |
1.2 | 248 | 41 | 10 | 3.28E+07 |
1.3 | 172 | 54 | 5 | 4.32E+07 |
2.1 | TNTC | 143 | 20 | 1.14E+08 |
2.2 | TNTC | 153 | 25 | 1.22E+08 |
2.3 | TNTC | 151 | 18 | 1.21E+08 |
3.1 | TNTC | 119 | 16 | 9.52E+07 |
3.2 | TNTC | 125 | 19 | 1.00E+08 |
3.3 | TNTC | 89 | 18 | 7.12E+07 |
4.1 | TNTC | 209 | 16 | 1.67E+08 |
4.2 | TNTC | 130 | 17 | 1.04E+08 |
4.3 | TNTC | 164 | 10 | 1.31E+08 |
US imaging
We use the Fujifilm VisualSonics / VEVO LAZR-X imaging system and MX250 transducer. The application is set to VA Phantom. Parameters are listed below:
Preparation before imaging: PBS solution is needed to cover the imaging samples allowing the transducer to dip into the solution. Pay attention to not producing any unwanted bubbles.